Investigation Overview
April 13, 2017 (Shareholders Foundation) - An investigation on behalf of investors in shares of Invivo Therapeutics Holdings Corp (NASDAQ:NVIV) was announced over potential breaches of fiduciary duties by certain officers and directors at Invivo Therapeutics Holdings. The investigation by a law firm concerns whether certain Invivo Therapeutics Holdings officers and directors breached...
You must register (for free) or login to view the entire investigation.